Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Authors: S. Vincent Rajkumar, Susanna Jacobus, Natalie S. Callander, Rafaël Fonseca, David H. Vesole, Michael E. Williams, Rafat Abonour, David S. Siegel, Michael B. Katz, Philip R. Greipp - The Lancet 2009 cited by 933